Investor Relations
News ReleasesRSS
- Dec 10, 2018 Establishment of "Gan with," an Information Website for Cancer Patients, Their Families and Coworkers
- Dec 07, 2018 Chugai Files for Additional Indication of Anti-PD-L1 Antibody TECENTRIQ® for Small Cell Lung Cancer
- Dec 06, 2018 Chugai Presents Interim Analysis Data of Phase I/II Study of SKY59, anti-C5 antibody in PNH at ASH
- Dec 06, 2018 Chugai Receives Orphan Drug Designation for TECENTRIQ® in Small cell Lung Cancer and for Entrectinib in NTRK Fusion-positive Solid Tumors
- Dec 05, 2018 Chugai Files Lawsuit against Alexion for Infringement of its Proprietary Antibody Engineering Technology in Japan
What's NewRSS
- Nov 12, 2018 Webcast of Information Meeting on GAZYVA®
- Nov 07, 2018 Information Meeting on GAZYVA®
- Oct 25, 2018 Webcast of 3Q Results (Jan-Sep 2018) Conference Call
- Oct 24, 2018 3Q Results (Jan-Sep 2018) Conference Call
- Oct 24, 2018 Financial Results for Third Quarter of Fiscal Year 2018 (Jan-Sep 2018)
